1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours

被引:0
|
作者
Vincenza Rita Lo Vasco
机构
[1] University of Rome,Faculty of Farmacia
来源
Journal of Neuro-Oncology | 2011年 / 103卷
关键词
Phospholipase C η2; Neuroblastoma; Oligodendroglioma; Chordoma; 1p36;
D O I
暂无
中图分类号
学科分类号
摘要
Deletions in the distal region of the short arm of chromosome 1 (1p36) are widely diffuse, both in congenital 1p36 Deletion Syndrome and as somatic abnormalities in tumours. Rearrangements in 1p36 have been described in a broad spectrum of human neoplasias in addition to other chromosomal abnormalities. In neuroblastomas, wide hemizygous deletions in 1p36.23–1p36.32 have been described suggesting that the 1p36 region contains a tumour-suppressor gene involved in malignancy. A role for phosphoinositide (PI)-specific phospholipase C (PLC) η2, whose gene maps on 1p36.32, was suggested. PI-PLC η2 belongs to a family of enzymes related to the phosphoinositide signalling pathway, which provide an important intracellular signalling system involved in a variety of cell functions such as hormone secretion, neurotransmitter signal transduction, cell growth, membrane trafficking, ion channel activity, regulation of the cytoskeleton, cell cycle control and apoptosis. Expression of PI-PLC η2 occurs after birth and continues throughout the life. Synapse formation occurs during a short period of postnatal development. Thus, it is likely that PI-PLC η2 acts in formation and maintenance of the neuronal network in the brain. The fact that PI-PLC η2, a highly neuron-specific isozyme, is abundantly expressed in the postnatal brain suggests the importance of PI-PLC η2 in formation and maintenance of the neuronal network in the postnatal brain. Further studies are required to verify the possible involvement of PI-PLC η2 mutation/deletion in central nervous tumour tissues presenting abnormalities of the 1p36 chromosomal band.
引用
收藏
页码:409 / 416
页数:7
相关论文
共 50 条
  • [21] An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes
    Cocco, Lucio
    Finelli, Carlo
    Mongiorgi, Sara
    Clissa, Cristina
    Russo, Domenico
    Bosi, Costanza
    Quaranta, Marilisa
    Malagola, Michele
    Parisi, Sarah
    Stanzani, Marta
    Ramazzotti, Giulia
    Mariani, Giulia A.
    Billi, Anna Maria
    Manzoli, Lucia
    Follo, Matilde Y.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 98 (05) : 769 - 780
  • [22] Biochemical characterization of the tomato phosphatidylinositol-specific phospholipase C (PI-PLC) family and its role in plant immunity
    Abd-El-Haliem, Ahmed M.
    Vossen, Jack H.
    van Zeijl, Arjan
    Dezhsetan, Sara
    Testerink, Christa
    Seidl, Michael F.
    Beck, Martina
    Strutt, James
    Robatzek, Silke
    Joosten, Matthieu H. A. J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (09): : 1365 - 1378
  • [23] Identification of two contiguous minimally deleted regions on chromosome 1p36.31–p36.32 in oligodendroglial tumours
    Z Dong
    JC-S Pang
    M H Ng
    W S Poon
    L Zhou
    H-K Ng
    British Journal of Cancer, 2004, 91 : 1105 - 1111
  • [24] Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes
    M Y Follo
    C Finelli
    S Mongiorgi
    C Clissa
    F Chiarini
    G Ramazzotti
    S Paolini
    G Martinelli
    A M Martelli
    L Cocco
    Leukemia, 2011, 25 : 271 - 280
  • [25] Role of tryptophan residues in the mechanism of the Ca+2 dependent phosphatidylinositol-specific phospholipase C (PI-PLC) from Streptomyces antibioticus
    Moyer, Tyler C.
    Selby, Thomas L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [26] Real-time PCR as a tool for quantitative analysis of PI-PLCβ1 gene expression in myelodysplastic syndrome
    Follo, Matilde Y.
    Bosi, Costanza
    Finelli, Carlo
    Fiume, Roberta
    Faenza, Irene
    Ramazzotti, Giulia
    Gaboardi, Gian Carlo
    Manzoli, Lucia
    Cocco, Lucio
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 18 (02) : 267 - 271
  • [27] PI-PLCβ-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes
    Follo, M. Y.
    Finelli, C.
    Bosi, C.
    Martinelli, G.
    Mongiorgi, S.
    Baccarani, M.
    Manzoli, L.
    Blalock, W. L.
    Martelli, A. M.
    Cocco, L.
    LEUKEMIA, 2008, 22 (01) : 198 - 200
  • [28] PI-PLCβ-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes
    M Y Follo
    C Finelli
    C Bosi
    G Martinelli
    S Mongiorgi
    M Baccarani
    L Manzoli
    W L Blalock
    A M Martelli
    L Cocco
    Leukemia, 2008, 22 : 198 - 200
  • [29] Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes
    Follo, M. Y.
    Finelli, C.
    Mongiorgi, S.
    Clissa, C.
    Chiarini, F.
    Ramazzotti, G.
    Paolini, S.
    Martinelli, G.
    Martelli, A. M.
    Cocco, L.
    LEUKEMIA, 2011, 25 (02) : 271 - 280
  • [30] Identification of tomato phosphatidylinositol-specific phospholipase-C (PI-PLC) family members and the role of PLC4 and PLC6 in HR and disease resistance
    Vossen, Jack H.
    Abd-El-Haliem, Ahmed
    Fradin, Emilie F.
    van den Berg, Grardy C. M.
    Ekengren, Sophia K.
    Meijer, Harold J. G.
    Seifi, Alireza
    Bai, Yuling
    ten Have, Arjen
    Munnik, Teun
    Thomma, Bart P. H. J.
    Joosten, Matthieu H. A. J.
    PLANT JOURNAL, 2010, 62 (02): : 224 - 239